CorMedix (CRMD)

• Market cap: $845M
• 1 day: -3.41%
• 5 days: -8.8%
• 1 month: -6.75%
• 3 months: -9.79%
• 6 months: -3.41%
• Year to date: 31.14%
• 1 year: 4.46%
• 5 years: 106.12%
• 10 years: -22.17%
• Sector: Healthcare
• Industry: Biotechnology

About: Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Employees: 82